(-)-demecolcine increases expression ISO RGD:1344593 6480464 Demecolcine results in increased expression of F5 mRNA CTD PMID:23649840 1-naphthyl isothiocyanate multiple interactions ISO RGD:1344593 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of F5 mRNA CTD PMID:27344345 17alpha-ethynylestradiol multiple interactions ISO RGD:1344593 6480464 F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of F5 mRNA CTD PMID:29097150 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1344593 6480464 Dihydrotestosterone results in increased expression of F5 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10557 6480464 Tetrachlorodibenzodioxin results in decreased expression of F5 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of F5 mRNA CTD PMID:32109520 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1344593 6480464 2 more ... CTD PMID:17547211 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of F5 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of F5 mRNA CTD PMID:21346803 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:10557 6480464 3 more ... CTD PMID:19467301 4,4'-diaminodiphenylmethane increases expression ISO RGD:10557 6480464 4, 4'-diaminodiphenylmethane results in increased expression of F5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:10557 6480464 bis4-hydroxyphenylsulfone results in increased expression of F5 mRNA CTD PMID:30951980 acenocoumarol decreases activity EXP 6480464 Acenocoumarol results in decreased activity of F5 protein CTD PMID:3490277 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of F5 mRNA CTD PMID:31881176 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of F5 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1344593 6480464 Aflatoxin B1 affects the expression of F5 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1344593 6480464 Aflatoxin B1 results in decreased methylation of F5 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:10557 6480464 Aflatoxin B1 results in decreased expression of F5 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases response to substance ISO RGD:1344593 6480464 F5 protein results in decreased susceptibility to Tretinoin CTD PMID:10734661 antimony(0) decreases expression ISO RGD:1344593 6480464 Antimony results in decreased expression of F5 mRNA CTD PMID:17547211 antirheumatic drug decreases expression ISO RGD:1344593 6480464 Antirheumatic Agents results in decreased expression of F5 mRNA CTD PMID:24449571 arsane decreases expression ISO RGD:10557 6480464 Arsenic results in decreased expression of F5 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:10557 6480464 Arsenic results in decreased expression of F5 mRNA CTD PMID:19654921 arsenous acid increases expression ISO RGD:1344593 6480464 Arsenic Trioxide results in increased expression of F5 mRNA CTD PMID:20458559 aspalathin multiple interactions ISO RGD:1344593 6480464 aspalathin inhibits the reaction [[F5 protein co-treated with F10 protein co-treated with Calcium Chloride] results in increased metabolism of F2 protein] CTD PMID:25325928 atorvastatin calcium decreases activity ISO RGD:1344593 6480464 Atorvastatin results in decreased activity of F5 protein CTD PMID:16907931 benzene increases expression ISO RGD:10557 6480464 Benzene results in increased expression of F5 mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene decreases expression ISO RGD:10557 6480464 Benzoapyrene results in decreased expression of F5 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1344593 6480464 Benzoapyrene affects the methylation of F5 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10557 6480464 Benzoapyrene results in increased expression of F5 mRNA CTD PMID:27195522 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1344593 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression ISO RGD:10557 6480464 bisphenol A results in decreased expression of F5 mRNA CTD PMID:21932408 bisphenol A increases expression ISO RGD:10557 6480464 bisphenol A results in increased expression of F5 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of F5 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of F5 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:10557 6480464 bisphenol F results in increased expression of F5 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:10557 6480464 1, 3-butadiene results in decreased expression of F5 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1344593 6480464 butyraldehyde results in decreased expression of F5 mRNA CTD PMID:26079696 cadmium atom affects binding ISO RGD:1344593 6480464 F5 protein binds to Cadmium CTD PMID:23896426 calcitriol increases expression ISO RGD:1344593 6480464 Calcitriol results in increased expression of F5 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1344593 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of F5 mRNA CTD PMID:21592394 calcium dichloride multiple interactions ISO RGD:1344593 6480464 [F5 protein co-treated with F10 protein co-treated with Calcium Chloride] results in increased metabolism of F2 protein more ... CTD PMID:25325928 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of F5 mRNA CTD PMID:23125180 chromium atom decreases expression ISO RGD:1344593 6480464 Chromium results in decreased expression of F5 mRNA CTD PMID:17547211 chrysene increases expression ISO RGD:10557 6480464 chrysene results in increased expression of F5 mRNA CTD PMID:26377693 clofibrate multiple interactions ISO RGD:10557 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of F5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of F5 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:10557 6480464 Clofibrate results in decreased expression of F5 mRNA CTD PMID:23811191 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of F5 mRNA CTD PMID:12851107 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of F5 mRNA CTD PMID:17602206 clomiphene affects response to substance ISO RGD:1344593 6480464 F5 gene polymorphism affects the susceptibility to Clomiphene CTD PMID:19371211 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of F5 mRNA CTD PMID:24386269 cyclosporin A decreases expression ISO RGD:10557 6480464 Cyclosporine results in decreased expression of F5 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1344593 6480464 Cyclosporine results in decreased expression of F5 mRNA CTD PMID:20106945 , PMID:25562108 cyproconazole decreases expression ISO RGD:10557 6480464 cyproconazole results in decreased expression of F5 mRNA CTD PMID:22334560 dextran sulfate multiple interactions ISO RGD:10557 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F5 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:1344593 6480464 Arsenic Trioxide results in increased expression of F5 mRNA CTD PMID:20458559 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of F5 mRNA CTD PMID:29108742 dichloroacetic acid decreases expression ISO RGD:10557 6480464 Dichloroacetic Acid results in decreased expression of F5 mRNA CTD PMID:28962523 dicrotophos increases expression ISO RGD:1344593 6480464 dicrotophos results in increased expression of F5 mRNA CTD PMID:28302478 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1344593 6480464 Antimony Potassium Tartrate results in decreased expression of F5 mRNA CTD PMID:17547211 dorsomorphin multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1344593 6480464 entinostat results in increased expression of F5 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of F5 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:10557 6480464 epoxiconazole results in decreased expression of F5 mRNA CTD PMID:22334560 Ethyl icosapentate decreases activity EXP 6480464 eicosapentaenoic acid ethyl ester results in decreased activity of F5 protein CTD PMID:14614217 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of F5 mRNA CTD PMID:24793618 folic acid increases expression ISO RGD:10557 6480464 Folic Acid results in increased expression of F5 mRNA CTD PMID:25629700 furan increases methylation EXP 6480464 furan results in increased methylation of F5 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of F5 mRNA CTD PMID:25539665 glycidol increases expression EXP 6480464 glycidol results in increased expression of F5 mRNA CTD PMID:24395379 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of F5 mRNA CTD PMID:22641619 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of F5 mRNA CTD PMID:24136188 levonorgestrel multiple interactions ISO RGD:1344593 6480464 F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 lithium chloride increases expression ISO RGD:1344593 6480464 Lithium Chloride results in increased expression of F5 mRNA CTD PMID:23527032 mercury atom decreases expression ISO RGD:1344593 6480464 Mercury results in decreased expression of F5 mRNA CTD PMID:17547211 mercury dibromide increases expression ISO RGD:1344593 6480464 mercuric bromide results in increased expression of F5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of F5 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO RGD:1344593 6480464 Mercury results in decreased expression of F5 mRNA CTD PMID:17547211 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of F5 mRNA CTD PMID:30467583 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of F5 mRNA CTD PMID:17602206 N-nitrosodimethylamine decreases expression ISO RGD:1344593 6480464 Dimethylnitrosamine results in decreased expression of F5 mRNA CTD PMID:17547211 nickel atom decreases expression ISO RGD:1344593 6480464 Nickel results in decreased expression of F5 mRNA CTD PMID:25583101 nickel dichloride decreases expression ISO RGD:1344593 6480464 nickel chloride results in decreased expression of F5 mRNA CTD PMID:17547211 ochratoxin A decreases expression ISO RGD:1344593 6480464 ochratoxin A results in decreased expression of F5 mRNA CTD PMID:19287073 p-chloromercuribenzoic acid increases expression ISO RGD:1344593 6480464 p-Chloromercuribenzoic Acid results in increased expression of F5 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of F5 mRNA CTD PMID:27188386 paracetamol multiple interactions ISO RGD:10557 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of F5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of F5 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:1344593 6480464 Acetaminophen results in decreased expression of F5 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:10557 6480464 Acetaminophen affects the expression of F5 mRNA CTD PMID:17562736 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 pentanal decreases expression ISO RGD:1344593 6480464 pentanal results in decreased expression of F5 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid affects expression ISO RGD:10557 6480464 perfluorooctane sulfonic acid affects the expression of F5 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:10557 6480464 perfluorooctane sulfonic acid results in decreased expression of F5 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression ISO RGD:10557 6480464 perfluorooctanoic acid affects the expression of F5 mRNA CTD PMID:19429403 phenobarbital affects expression ISO RGD:10557 6480464 Phenobarbital affects the expression of F5 mRNA CTD PMID:23091169 phenprocoumon decreases activity EXP 6480464 Phenprocoumon results in decreased activity of F5 protein CTD PMID:3490277 phenylmercury acetate increases expression ISO RGD:1344593 6480464 Phenylmercuric Acetate results in increased expression of F5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of F5 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:10557 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of F5 mRNA, PPARA protein promotes the reaction [pirinixic acid results in decreased expression of F5 mRNA] CTD PMID:18467677 , PMID:19710929 pirinixic acid decreases expression ISO RGD:10557 6480464 pirinixic acid results in decreased expression of F5 mRNA CTD PMID:18467677 , PMID:23811191 potassium dichromate decreases expression ISO RGD:1344593 6480464 Potassium Dichromate results in decreased expression of F5 mRNA CTD PMID:17547211 propanal decreases expression ISO RGD:1344593 6480464 propionaldehyde results in decreased expression of F5 mRNA CTD PMID:26079696 propiconazole decreases expression ISO RGD:10557 6480464 propiconazole results in decreased expression of F5 mRNA CTD PMID:21278054 , PMID:22334560 quinapril hydrochloride decreases activity ISO RGD:1344593 6480464 Quinapril results in decreased activity of F5 protein CTD PMID:16907931 rotenone affects expression EXP 6480464 Rotenone affects the expression of F5 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1344593 6480464 sodium arsenite results in decreased expression of F5 mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of F5 mRNA CTD PMID:22110744 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of F5 mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:1344593 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of F5 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1344593 6480464 Testosterone results in increased expression of F5 mRNA CTD PMID:21592394 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of F5 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:10557 6480464 Carbon Tetrachloride results in decreased expression of F5 mRNA CTD PMID:31919559 titanium dioxide multiple interactions ISO RGD:10557 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F5 mRNA CTD PMID:29950665 tolcapone increases expression EXP 6480464 tolcapone results in increased expression of F5 mRNA CTD PMID:24136188 trichostatin A increases expression ISO RGD:1344593 6480464 trichostatin A results in increased expression of F5 mRNA CTD PMID:24935251 Triptolide increases expression EXP 6480464 triptolide results in increased expression of F5 protein CTD PMID:32519852 valproic acid affects expression ISO RGD:1344593 6480464 Valproic Acid affects the expression of F5 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1344593 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of F5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1344593 6480464 Valproic Acid results in increased expression of F5 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of F5 mRNA CTD PMID:23034163 warfarin affects response to substance ISO RGD:1344593 6480464 F5 gene polymorphism affects the susceptibility to Warfarin, F5 protein affects the susceptibility to Warfarin CTD PMID:19752777 warfarin decreases activity EXP 6480464 Warfarin results in decreased activity of F5 protein CTD PMID:3490277 zinc atom increases expression ISO RGD:10557 6480464 Zinc deficiency results in increased expression of F5 mRNA CTD PMID:20857495 zinc atom increases expression ISO RGD:1344593 6480464 Zinc deficiency results in increased expression of F5 mRNA CTD PMID:22171008 zinc(0) increases expression ISO RGD:10557 6480464 Zinc deficiency results in increased expression of F5 mRNA CTD PMID:20857495 zinc(0) increases expression ISO RGD:1344593 6480464 Zinc deficiency results in increased expression of F5 mRNA CTD PMID:22171008